GlaxoSmithKline

GSK
Real-time CHI-X EUROPE LIMITED. - 02/25 04:44:20 am
1628.7GBp
+0.02%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
GlaxoSmithkline is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows:
- pharmaceutical products (56%): intended for respiratory diseases (40.1% of net sales), HIV infection (27.3%), immune system disorders (2.7%) ) and other (29,8%);
- OTC and parapharmaceutical medicine (29.8%);
- vaccines (19,1%).
Net sales break down geographically as follows: the United Kingdom (3%), the United States (38.9%) and other (58.1%).
Sales per Businesses
20172018
GBP
(in Million)
%GBP
(in Million)
%
Pharmaceuticals 17,27657.2% 17,26956%
Consumer Healthcare 7,75025.7% 7,65824.8%
Vaccines 5,16017.1% 5,89419.1%
Sales per Regions
20172018
GBP
(in Million)
%GBP
(in Million)
%
United States 11,26337.3% 11,98238.9%
International 10,98036.4% 10,86635.3%
Europe 7,00323.2% 7,05022.9%
United Kingdom 940.003.1% 923.003%
Managers
Name Title
Emma N. Walmsley Chief Executive Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Iain James Mackay Chief Financial Officer & Executive Director
Karenann K. Terrell Chief Technology & Digital Officer
Hal V. Barron Executive Director & Chief Scientific Officer
Jon Ellis Vice President & Head-Science & Technology
Judy Carol Lewent Independent Non-Executive Director
Lynn Laverty Elsenhans Independent Non-Executive Director
Urs Rohner Independent Non-Executive Director
Manvinder Singh Banga Senior Independent Non-Executive Director
Shareholders
Name Equities %
The Vanguard Group, Inc. 149,160,000 2.99%
BlackRock Fund Advisors 130,661,000 2.62%
BlackRock Investment Management (UK) Ltd. 128,982,522 2.59%
Norges Bank Investment Management 121,995,000 2.44%
Legal & General Investment Management Ltd. 102,889,300 2.06%
Capital Research & Management Co. (Global Investors) 75,487,000 1.51%
Schroder Investment Management Ltd. 71,784,674 1.44%
Dodge & Cox 66,621,000 1.34%
Capital Research & Management Co. (World Investors) 63,727,000 1.28%
Threadneedle Asset Management Ltd. 62,762,642 1.26%
Company contact information
980 Great West Road
TW8 9GS Brentford, Greater London
United Kingdom

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
Sector Pharmaceuticals - NEC
1st jan.Capi. (M$)
GLAXOSMITHKLINE PLC-10.79%104 842
JOHNSON & JOHNSON2.78%395 024
ROCHE HOLDING AG10.13%300 195
NOVARTIS2.72%218 568
MERCK AND COMPANY-10.58%209 636
PFIZER-8.83%197 679
NOVO NORDISK AS13.46%149 779
BRISTOL-MYERS SQUIBB COMPANY2.24%147 733
ABBVIE INC.5.20%140 461
AMGEN INC.-7.58%131 403
ASTRAZENECA PLC-2.12%130 836
ELI LILLY AND COMPANY5.11%128 743
SANOFI2.18%127 112
GLAXOSMITHKLINE-8.39%106 997
BAYER AG-3.17%79 066
ALLERGAN PLC4.70%65 850
CHUGAI PHARMACEUTICAL CO., LTD.0.70%60 073
TAKEDA PHARMACEUTICAL COMPANY LIMITED1.56%58 979
JIANGSU HENGRUI MEDICINE CO., LTD.3.06%56 516
DAIICHI SANKYO COMPANY, LIMITED-0.49%44 408
ASTELLAS PHARMA INC.-1.11%31 870
Brand Portfolio
GLAXOSMITHKLINE
GLAXOSMITHKLINE
GSK
GSK
CELLZOME
CELLZOME
CORIXA
CORIXA
DOMANTIS
DOMANTIS
GENELABS TECHNOLOGIES
GENELABS TECHNOLOGIES
GLYCOVAXYN
GLYCOVAXYN
STIEFEL
STIEFEL
TESARO
TESARO
More brands of GlaxoSmithKline